Results 121 to 130 of about 6,841 (195)

Ningmitai capsule in patients with chronic prostatitis/chronic pelvic pain syndrome: a multicenter, prospective, randomized, parallel, positive-controlled study. [PDF]

Front Pharmacol
Gao J, Zhang Y, Du J, Liu Q, Cheng Y, Yang W, Wang D, Wang W, Zheng L, Wang D, Wu L, Jiang X, Men Q, Liang C, Zhang X.   +14 more
europepmc   +1 more source

Do Alpha-Blockers and 5-Alpha Reductase Inhibitors Increase Dementia Risk? A Network Meta-analysis. [PDF]

Int Neurourol J
Niaga KJK, Rinaldi FX, Nathania N, Supinto PA, Lionardi SK, Yo R, Wilyono A, Silalahi PY.   +7 more
europepmc   +1 more source

Off-label prescribing of tamsulosin: A nationwide retrospective study combining prescription and regulatory data. [PDF]

Explor Res Clin Soc Pharm
Artner A, Niedermüller Á, Csapó MA, Hanh NN, Fekete E, Zelkó R, Sebők S.   +6 more
europepmc   +1 more source

A REVIEW ON RECENT ADVANCES IN TRANSDERMAL DRUG DELIVERY SYSTEMS OF TAMSULOSIN

Tamsulosin is a highly selective α1-adrenoreceptor antagonist. It has been developed to treat signs and symptoms of benign prostatic hyperplasia. Tamsulosin is absorbed quickly and completely in intestinal mucosa and is eliminated gradually after oral ...
GHANEM, AYA M.
core  

Postoperative Urinary Retention After Hernia Repair: A Randomized Controlled Trial Identifying Patients at Risk and Assessing the Incidence After Tamsulosin Pretreatment. [PDF]

HCA Healthc J Med
Epps BM, Coile E, Carey M, Whipple O, Kelly R, Senkowski C, Garber J.   +6 more
europepmc   +1 more source

Evaluation of a low-intensity pulsed ultrasound for chronic prostatitis type IIIb/chronic pelvic pain syndrome: a randomized controlled trial. [PDF]

Front Reprod Health
Huang J, Liao Z, Zhao S, Lv B, Liang K.
europepmc   +1 more source

A systematic review and meta-analysis of the efficacy and safety of mirabegron vs. tamsulosin in alleviating double-J catheter related symptoms. [PDF]

Front Med (Lausanne)
Zhang J, Wang D, Chi J, Lou K, Wu J, Cui Y.   +5 more
europepmc   +1 more source

Real-world safety assessment of tamsulosin based on adverse event analysis from the FAERS database. [PDF]

Sci Rep
Zhang Z, Lv L, Jiang F, Guan S, He D, Song H, Sun W, Tian F, Jiang S.   +8 more
europepmc   +1 more source

Efficacy of external physical vibration lithecbole combined with tamsulosin in upper ureteric stones after ESWL: a prospective randomized clinical trial. [PDF]

Sci Rep
Xu HW, Liang X, Wang YH, Xu YX, Li HQ, Li YP.   +5 more
europepmc   +1 more source

Efficacy and Safety of Mirabegron in Males with Overactive Bladder and Lower Urinary Tract Symptoms: Analysis from an Integrated Database. [PDF]

Eur Urol Open Sci
Hadi FA, Schild A, Hansen MK, Anaokar S, Herschorn S.   +4 more
europepmc   +1 more source